Experienced in producing high potency products on a large scale:
- Batch – fast, simple, proof of concept
- Fed-batch – high cell density, cost-effective
- Continuous – smaller footprint, higher volumetric productivity, reduced capital, strain adaptation

— Fauad Hasan,“I have worked with the Ingenza team for over a decade and have always appreciated their bioprocessing expertise and capabilities in support of several key projects both during my time at big biopharma and start-ups. I consider them a trusted and valued partner.”
former CEO, Bonti